Prevalence of human papillomavirus in 45 Greek patients with oral cancer

Journal of Oncology

Volumn , Issue , 2013, Pages

  Kouvousi, Maria ^a   Xesfyngi, Dimitra ^a   Tsimplaki, Elpida ^a   Argyri, Elena ^a   Ioannidou, Georgia ^a   Ploxorou, Maria ^a   Lazaris, Andreas C ^b   Patsouris, Efstratios ^b   Panotopoulou, Efstathia ^a  

^a Regional Anticancer Oncology Hospital of Athens St Savvas   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; MESSENGER RNA; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENOTYPE; GREECE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PREVALENCE; VIRUS DETECTION; VIRUS IDENTIFICATION; WART VIRUS;

EID: 84875517239     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2013/756510     Document Type: Article

References (23)

1. Wang S. S., Zuna R. E., Wentzensen N., Dunn S. T., Sherman M. E., Gold M. A., Schiffman M., Wacholder S., Allen R. A., Block I., Downing K., Jeronimo J., Carreon J. D., Safaeian M., Brown D., Walker J. L., Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiology Biomarkers and Prevention 2009 18 1 113 120 2-s2.0-58349115422 10.1158/1055-9965.EPI-08-0591
2. Castle P. E., Cox J. T., Schiffman M., Wheeler C. M., Solomon D., Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology. Obstetrics and Gynecology 2008 112 3 637 645 2-s2.0-55949091184 10.1097/AOG.0b013e3181834637
3. Rubenstein L. M., Smith E. M., Pawlita M., Haugen T. H., Hamsikova E., Turek L. P., Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infectious Agents and Cancer 2011 6 article 9 2-s2.0-79960026200 10.1186/1750-9378-6-9
4. Turner D. O., Cocks S. J., Bullen R., High-risk Human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health 2011 11 article 28 10.1186/1472-6831-11-28
5. Saavedra G. A., Amador V. R., Camacho M. E. I., Cuellar C. M. G., Jiménez M. G., Martínez R. M., Carrancá A. G., High association of human papillomavirus infection with oral cancer: a case-control study. Archives of Medical Research 2008 39 2 189 197 2-s2.0-37349059585 10.1016/j.arcmed.2007.08.003 (Pubitemid 350299619)
6. Feller L., Wood N. H., Khammissa R. A. G., Lemmer J., Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma-part 2: human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head and Face Medicine 2010 6 1, article 15 2-s2.0-77954552752 10.1186/1746-160X-6-15
7. Fröberg M., Johansson B., Hjerpe A., Andersson S., Human papillomavirus "reflex" testing as a screening method in cases of minor cytological abnormalities. The British Journal of Cancer 2008 99 4 563 568 2-s2.0-49549102184 10.1038/sj.bjc.6604504
8. Kumaraswamy K. L., Vidhya M., Human papilloma virus and oral infections: an update. Journal of Cancer Research and Therapeutics 2011 7 2 120 127 2-s2.0-79960798800 10.4103/0973-1482.82915
9. Begum S., Cao D., Gillison M., Zahurak M., Westra W. H., Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clinical Cancer Research 2005 11 16 5694 5699 2-s2.0-23844532582 10.1158/1078-0432.CCR-05-0587 (Pubitemid 41170292)
10. St Guily J. L., Clavel C., Okaïs C., Human papillomavirus genotype distribution in tonsil cancers. Head and Neck Oncology 2011 3 1, article 6 10.1186/1758-3284-3-6
11. Pathare S. M., Gerstung M., Beerenwinkel N., Schäffer A. A., Kannan S., Pai P., Pathak K. A., Borges A. M., Mahimkar M. B., Clinicopathological and prognostic implications of genetic alterations in oral cancers. Oncology Letters 2011 2 3 445 451 2-s2.0-79953276797 10.3892/ol.2011.271
12. Zhang D., Zhang Q., Zhou L., Huo L., Zhang Y., Shen Z., Zhu Y., Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer 2010 10, article 650 2-s2.0-78649334484 10.1186/1471-2407-10- 650
13. Jung A. C., Briolat J., Millon R., de Reyniès A., Rickman D., Thomas E., Abecassis J., Clavel C., Wasylyk B., Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. International Journal of Cancer 2010 126 8 1882 1894 2-s2.0-77949890036 10.1002ijc.24911
14. Pannone G., Santoro A., Papagerakis S., Lo Muzio L., de Rosa G., Bufo P., The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma:an overview. Infectious Agents and Cancer 2011 6 1, article 4 2-s2.0-79953124785 10.1186/1750-9378-6-4
15. Pannone G., Rodolico V., Santoro A., Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization. Infectious Agents and Cancer 2012 7 article 4 10.1186/1750-9378-7-4
16. Kuo K. T., Hsiao C. H., Lin C. H., Kuo L. T., Huang S. H., Lin M. C., The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Modern Pathology 2008 21 4 376 386 2-s2.0-41149173816 10.1038/modpathol.3800979 (Pubitemid 351441025)
17. Hocking J. S., Stein A., Conway E. L., Regan D., Grulich A., Law M., Brotherton J. M. L., Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. The British Journal of Cancer 2011 104 5 886 891 2-s2.0-79952281272 10.1038/sj.bjc.6606091
18. Goon P. K., Stanley M. A., Ebmeyer J., Steinsträsser L., Upile T., Jerjes W., Bernal-Sprekelsen M., Görner M., Sudhoff H. H., HPV & head and neck cancer: a descriptive update. Head & Neck Oncology 2009 1 article 36 2-s2.0-77953450510
19. Afonso L. A., Moysés N., Cavalcanti S. M., Human papillomavirus detection and p16 methylation pattern in a case of esophageal papilloma. Brazilian Journal of Medical and Biological Research 2010 43 7 694 696 10.1590/S0100-879X2010007500055
20. Syrjänen S., The role of human papillomavirus infection in head and neck cancers. Annals of Oncology 2010 21 supplement 7 vii243 vii245 10.1093/annonc/mdq454
21. Marklund L., Hammarstedt L., Impact of HPV in oropharyngeal cancer. Journal of Oncology 2011 2011 6 2-s2.0-79952235582 10.1155/2011/509036 509036
22. Ribeiro K. B., Levi J. E., Pawlita M., Koifman S., Matos E., Eluf-Neto J., Wunsch-Filho V., Curado M. P., Shangina O., Zaridze D., Szeszenia-Dabrowska N., Lissowska J., Daudt A., Menezes A., Bencko V., Mates D., Fernandez L., Fabianova E., Gheit T., Tommasino M., Boffetta P., Brennan P., Waterboer T., Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. International Journal of Epidemiology 2011 40 2 489 502 2-s2.0-79953717110 10.1093/ije/dyq249 dyq249
23. D'Souza G., Case control study of human papillomavirus and oropharyngeal cancer. The New England Journal of Medicine 2007 356 19 1944 1956 10.1056/NEJMoa065497 (Pubitemid 46740304)